Higher CD4/CD8 ratio of pleural effusion predicts better survival for lung cancer patients receiving immune checkpoint inhibitors
Abstract Pleural effusion is a rare immune-related adverse event for lung cancer patients receiving immune checkpoint inhibitors (ICIs). We enrolled 281 lung cancer patients treated with ICIs and 17 were analyzed. We categorized the formation of pleural effusion into 3 patterns: type 1, rapid and ma...
Saved in:
Main Authors: | Po-Hsin Lee, Tsung-Ying Yang, Kun-Chieh Chen, Yen-Hsiang Huang, Jeng-Sen Tseng, Kuo-Hsuan Hsu, Yu-Chen Wu, Ko-Jiunn Liu, Gee-Chen Chang |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/f228d1a7f51f4cfea43483e9f6b1b3c4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anaphylatoxins orchestrate Th17 response via interactions between CD16+ monocytes and pleural mesothelial cells in tuberculous pleural effusion.
by: Shuanglinzi Deng, et al.
Published: (2021) -
Acute myeloid leukemia with leukemic pleural effusion and high levels of pleural adenosine deaminase: A case report and review of literature
by: Wang Sing-Ting, et al.
Published: (2021) -
Soluble CD40 in plasma and malignant pleural effusion with non-small cell lung cancer: A potential marker of prognosis
by: Chuan-Yong Mu, et al.
Published: (2015) -
Potential diagnostic value of pleural fluid cytokines levels for tuberculous pleural effusion
by: Neda Dalil Roofchayee, et al.
Published: (2021) -
Diagnostic yield and safety of closed needle pleural biopsy in exudative pleural effusion
by: Govind Singh Rajawat, et al.
Published: (2017)